Invesco Ltd. - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 46 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q4 2017$77,000
-78.5%
10,500
-79.3%
0.00%
Q3 2017$358,000
-28.4%
50,764
-28.9%
0.00%
Q2 2017$500,000
+2.9%
71,354
+1.8%
0.00%
Q1 2017$486,000
+20.0%
70,090
-4.9%
0.00%
Q4 2016$405,000
+6.3%
73,690
-3.3%
0.00%
Q3 2016$381,000
+14.1%
76,190
+2.7%
0.00%
Q2 2016$334,000
-4.8%
74,190
-5.1%
0.00%
Q1 2016$351,000
-18.2%
78,190
-4.2%
0.00%
Q4 2015$429,000
-12.1%
81,640
-3.6%
0.00%
Q3 2015$488,000
-19.5%
84,6900.0%0.00%
Q2 2015$606,000
+2.5%
84,690
-4.5%
0.00%
Q1 2015$591,000
+83.5%
88,640
+64.6%
0.00%
Q4 2014$322,000
+21.1%
53,8400.0%0.00%
Q3 2014$266,000
+1.5%
53,840
-7.6%
0.00%
Q2 2014$262,000
-2.2%
58,240
-2.2%
0.00%
Q1 2014$268,000
-10.4%
59,540
+1.9%
0.00%
Q4 2013$299,000
+12.8%
58,420
-0.3%
0.00%
Q3 2013$265,000
-44.9%
58,600
-37.8%
0.00%
Q2 2013$481,00094,1500.00%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q1 2015
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,218,401$6,957,0004.07%
BARD ASSOCIATES INC 395,575$2,260,0000.21%
Ariel Investments 1,290,317$7,368,0000.08%
Ballew Advisors, Inc 5,557$31,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 205,400$1,173,0000.01%
DELTA ASSET MANAGEMENT LLC/TN 12,000$68,0000.01%
Oakworth Capital, Inc. 3,052$17,0000.00%
Spark Investment Management LLC 10,800$61,0000.00%
DIMENSIONAL FUND ADVISORS LP 878,348$5,015,0000.00%
Renaissance Technologies 381,471$2,178,0000.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders